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Abstract
Background: Old age at diagnosis is associated with poor survival in colorectal cancer (CRC) for unknown reasons.
Recent data show that colonoscopy is efficient in preventing left-sided cancers only. We examine the association of
Tumor Node Metastasis (TNM) classes with diagnostic age and patient characteristics.
Methods: The Swedish Family-Cancer Database has data on TNM classes on 6,105 CRC adenocarcinoma patients.
Ordinal logistic regression analysis was performed to model tumor characteristics according to age at diagnosis,
tumor localization, gender, socioeconomic status, medical region and family history. The results were compared to
results from survival analysis.
Results: The only parameters systematically associated with TNM classes were age and tumor localization. Young
age at diagnosis was a risk factor for aggressive CRC, according to stage, N and M with odds ratios (ORs) ranging
from 1.80 to 1.93 for diagnosis before age 50 years compared to diagnosis at 80+ years. All tumor characteristics,
particularly T, were worse for colon compared to rectal tumors. Right-sided tumors showed worse characteristics
for all classifiers but M. The survival analysis on patients diagnosed since 2000 showed a hazard ratio of 0.55 for
diagnosis before age 50 years compared to diagnosis at over 80 years and a modestly better prognosis for left-
sided compared to right-sided tumors.
Conclusions: The results showed systematically more aggressive tumors in young compared to old patients. The
poorer survival of old patients in colon cancer was not related to the available tumor characteristics. However,
these partially agreed with the limited colonoscopic success with right-sided tumors.
Background
Mortality in colorectal cancer (CRC) has declined in the
developed countries because the incidence has no longer
increased and because the survival has improved [1-3].
Adenocarcinoma is the most common histology of
colon and rectal cancers. The 5-year survival for colon
adenocarcinoma reached about 60% in Sweden towards
the end of the 1990s being a few percentage points bet-
ter for women compared to men [4]; for rectal adeno-
carcinoma the male survival was about 55% compared
to over 60% for women. The reasons for the improve-
ments in survival have been suggested to be earlier diag-
nosis and better health status and care [4,5]. However,
the favorable development has not benefitted equally all
patients. The survival in elder l yp a t i e n t si sp o o r e rt h a n
that of the young patients [6]. Nevertheless, the differ-
ences in survival and treatment response tend to be
small in clinical trials on fit elderly patients [7,8]. The
age differences are larger for colon than rectal cancer in
most but not all studies [9]. In colon cancer, the risk of
dying is about twice as high as in those diagnosed at age
over 75 years compared to those diagnosed before age
60 years [10,11]. The reasons for the differential survival
have been unclear and factors such as late seeking of
care, co-morbidities, less aggressive treatment and dis-
continued treatment have been invoked [6,9,12,13]. If
delayed diagnosis were the reason for the poor survival,
tumor characteristics would show more advanced stages
in older patients. Results on tumor characteristics of
colorectal tumors have been ambiguous but the recent
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younger patients present more aggressive and advanced
tumors [11,14-16]. High education level has been shown
to correlate with better survival in colon cancer and
somewhat better survival in rectal cancer [17]. Family
history of particularly colon cancer appears to be asso-
ciated with better survival, which has also been observed
for hereditary nonpolyposis colorectal cancer (HNPCC)
patients [18-20].
The Swedish Cancer Registry has recently started to
record tumor characteristics based on the TNM classifi-
cation. We use these data, accumulated over four years
between 2004 and 2008, to assess the distribution of the
characteristics of the patients and their proximal and dis-
tal colon cancers and rectal cancer according to stage
and TNM classes in a total of 6,105 CRC adenocarci-
noma patients. We carried out also a survival study by
tumor localization on patients diagnosed since 2000. The
TNM findings are discussed in terms of age-dependent
survival and recent evidence that colonoscopy is effective
in preventing left-sided tumors only [21,22].
Methods
The population-based Swedish Family-Cancer Database
was created by linking the Multigeneration Register at
Statistics Sweden to the Swedish Cancer Registry
[23-25]. The Multigeneration Register includes indivi-
duals born in Sweden after 1931 and their biological
parents, providing registered information of the Swedish
families through the past century [24,25]. The Swedish
Cancer Registry is based on compulsory reports about
patients provided by pathologists and cytologists, who
report every cancer diagnosis on surgically removed tis-
sue, biopsies, cytological specimens, bone marrow aspi-
rates and autopsies [23]. Both the diagnostic accuracy
and coverage are believed to approach 100%; in recent
years over 5000 CRCs were annually diagnosed and
between 100-150 cases were additionally reported in
death certificates but not included in the Cancer Regis-
try [23]. The Database comprises more than 12 million
individuals and over 1 million first primary cancers
[24,25]. Data on patients with cancer were retrieved
from the Swedish Cancer Registry from 1958 to 2008.
International Classification of Disease (ICD-7) codes
153.0 to 153.3 and 154.0 were used for CRC and
120,125 cases were identified, 93% of which were adeno-
carcinomas, according to the pathological anatomic
diagnosis code 096. Based on the codes, the anatomic
location of colon was classified as right-sided sections
(proximal, codes 153.0 and 153.1) and left-sided sections
(distal, codes 153.2 and 153.3). The splenic flexure was
the dividing line of the left and the right locations.
Tumor depth of invasion, nodal status and presence of
metastatic disease were available since 2002 according to
the TNM system introduced by the American Joint
Committee on Cancer [26]. ‘T’ described for how far the
primary tumor has grown into the wall of the intestine
and whether it has grown into nearby tissues; ‘N’ gives
the extent of spread to nearby (regional) lymph nodes;
‘M’ indicates whether the cancer has spread (metasta-
sized) to other organs of the body. Numbers or letters
appear after T, N and M to provide more details about
each of these factors. The numbers 0 through 4 indicate
increasing severity. More than 99% over the TNM clas-
sifications were clinical rather than pathological but no
data were available on the diagnostic criteria used. We
limited the present study to cover two of six Swedish
healthcare regions (Stockholm-Gotland and Linköping),
because of the lowest level of missing data on TNM
classes (10%). Once a person’s T, N and M categories
were determined, the information was combined to
‘stage’ [26], ranging from stage I (the least advanced) to
stage IV (the most advanced). The definitions of stage
w e r ea sf o l l o w s :s t a g eI( T 1o rT 2N 0M 0 ) ,s t a g eI I( T 3
or T4 N0 M0), stage III (any T N1 or N2 M0) and stage
IV (any T or N M1).
We analyzed the survival of 10,174 patients diagnosed
with colorectal adenocarcinoma in Stockholm-Gotland
and Linköping regions from 2000 to 2008, based on the
Cox model using time since diagnosis (in months) as
the underlying time scale (PROC PHREG, SAS Version
9.2). We investigated the association between CRC-
specific mortality and age at diagnosis, gender, socioeco-
nomic status, medical region at diagnosis, location of
t h et u m o r ,f i r s t - d e g r e ef a m ily history (parent and sib-
ling) of CRC. The data on socioeconomic status was
obtained from the national census of 1990 and grouped
in six classes: agriculture, worker, blue collar, profes-
sional, private and other. The results were summarized
as hazard ratios (HRs). Note that the HR compares the
death rate of CRC patients to that of the population
considering the above variables, including age. Follow-
up started at the time of diagnosis. Censoring events
were defined as death from other cause than colorectal
cancer, diagnosis of second cancer, emigration, and end
of the study (December 31, 2008). A p value of <0.05
was considered statistically significant.
The reporting of TNM data to Cancer Registry was
lowest in the first years starting in 2002; thus the analy-
sis of TNM data was started from year 2004 and
extended through 2008. Ordinal logistic regression mod-
els were first used to estimate the risk to be at an
advanced stage (stage III/IV vs stage I/II) and then to
calculate risks for T (T3/T4 vs T1/T2), N (N1/N2 vs
N0) and M (M1 vs M0). For each variable, risks were
calculated against the reference category, set at 1.00.
Independent predictors were side, age, gender, socioeco-
nomic status, medical region, and first-degree family
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9.2 statistical package using the Logistic procedure [27].
Results
A survival study on 10,174 CRC patients diagnosed from
2000 to 2008 covered the most recent survival trends for
Sweden. The results in Table 1 showed that patients diag-
nosed at younger age survived systematically better, HR
being 0.55 for those diagnosed below age 50 years com-
pared to those diagnosed at age 80+ years. Women sur-
vived somewhat better than men, HR 0.88. Family history
showed no significant effect. Tumor localization had a
small but significant effect, transverse colon with the high-
est risk (1.25) and rectum (1.00) and sigmoid (1.03) the
lowest risks. The data were additionally adjusted for socio-
economic status and medical region (data not shown).
The study population of the TNM study comprised of
6,105 CRC patients is described in Table 2 by the key
variables. Young patients (diagnosis before age 50 years)
accounted for 4 to 7% of all patients. Patients diagnosed
at age 80+ years accounted for 35.4% of the cases in
ascending colon and the proportion decreased progres-
sively along colon, reaching 20.6% in rectum. Women
accounted for the majority of right-sided cases (55.0%)
but not of the left-sided (47.9%) or rectal cancer samples
(43.6%). Less than 7% of the patients had a family his-
tory of CRC, as diagnosed between 2004 and 2008.
Table 3 shows the distribution of tumor characteristics
in CRC patients based on the ordinal logistic regression
model. The patients diagnosed before age 50 years
showed more advanced stage compared to 80+ year old
(OR 1.80) which was explained by more lymph node
metastasis (N, OR 1.93) and distant metastasis (M, OR
1.88); all these were significant at p < 0.0001 to p <
0.01, and they showed a systematic age gradient. Right-
sided tumors were more advanced than left-sided
tumors for stage (1.45 vs. 1.19, rectum is reference,
1.00), T (3.30 vs. 2.12) and N (1.60 vs. 1.16) but not for
M. All colonic subsites showed more advanced charac-
teristics compared to the rectum. No sex differences
were seen; nor were data on family history significant
(not shown).
Discussion
We showed first that even for CRC diagnosed since
2000, young age at diagnosis was a favorable prognostic
factor; the HR was 0.55 for those diagnosed before age
50 years compared to diagnosis at age 80+. Tumor loca-
lization played a minor role in survival. Left-sided
tumors showing the lowest HR of 1.04 compared to
1.16 for right-sided tumors (rectum was reference, HR
1.00). Among colonic subsites, tumors in transverse
colon were associated with the worst survival (1.25) and
sigmoid the best survival (1.03). These small differences
Table 1 Hazard ratios and 95% confidence intervals (CIs) for cause-specific survival in left- and right-sided colon and
rectal adenocarcinoma patients diagnosed from 2000 to 2008
Number of cases Number of events Global P-value Adjusted HR 95%CI
Age at diagnosis <.0001
<50 566 132 0.55 0.46-0.67
50-59 1260 336 0.69 0.61-0.79
60-69 2563 592 0.63 0.57-0.71
70-79 3040 909 0.86 0.78-0.94
80+ 2745 889 1.00
Gender <0.01
Female 4949 1383 0.88 0.82-0.95
Male 5225 1475 1.00
Family history
Yes 534 120 0.89 0.74-1.08
No 9640 2738 1.00
Side <0.01
Right-side 3735 1122 1.16 1.07-1.27
Ascending 2495 733 1.12 1.02-1.24
Transverse 1240 389 1.25 1.11-1.40
Left-side 2618 707 1.04 0.95-1.15
Descending 281 77 1.15 0.91-1.45
Sigmoid 2337 630 1.03 0.94-1.14
Rectum 3821 1029 1.00
HRs additionally adjusted for socioeconomic status and medical region.
The significant P values and HRs are shown in bold.
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[28]. These data were not adjusted for TNM because
the classification system was established first in 2002 in
the Swedish Cancer Registry and a lot of data were
missing in the first year or two. This was a major limita-
tion of the study. Of course, lacking of data on treat-
ment was another limitation.
We used the TNM classification system to address a
number of hypotheses: are tumors more advanced in
older patients or in men or in those lacking a family
history because all these characteristics have been asso-
ciated with poor survival, particularly in colon cancer
[6,10,11,17-20]. For colon and rectal cancers survival has
been better for women than for men [4,10]. Unfortu-
nately, the Swedish Cancer Registry collects no detailed
data on which diagnostic tests were being used to estab-
lish the TNM class.
The results of the study on CRC adenocarcinoma
patients with TNM data were clear in concluding that
gender and family history were not determinants of
Table 2 Characteristics of the study populations diagnosed from 2004 to 2008
Right Side Ascending Transverse Left Side Descending Sigmoid Rectum
N%N%N %N%N% N%N%
Age at diagnosis
<50 102 4.6 63 4.2 39 5.2 103 6.4 12 6.9 91 6.4 137 6.0
50-59 189 8.4 125 8.4 64 8.5 215 13.4 27 15.5 188 13.2 359 15.8
60-69 528 23.6 327 22.0 201 26.8 433 27.1 42 24.1 391 27.4 703 31.0
70-79 644 28.8 445 29.9 199 26.5 485 30.3 54 31.0 431 30.2 602 26.6
80+ 775 34.6 527 35.4 248 33.0 364 22.8 39 22.4 325 22.8 466 20.6
Total 2238 100.0 1487 100.0 751 100.0 1600 100.0 174 100.0 1426 100.0 2267 100.0
Gender
Female 1232 55.0 850 57.2 382 50.9 767 47.9 86 49.4 681 47.8 989 43.6
Male 1006 45.0 637 42.8 369 49.1 833 52.1 88 50.6 745 52.2 1278 56.4
Total 2238 100.0 1487 100.0 751 100.0 1600 100.0 174 100.0 1426 100.0 2267 100.0
Family history
Yes 129 5.8 79 5.3 50 6.7 90 5.6 12 6.9 1348 5.5 133 5.9
No 2109 94.2 1408 94.7 701 93.3 1510 94.4 162 93.1 78 94.5 2134 94.1
Total 2238 100.0 1487 100.0 751 100.0 1600 100.0 174 100.0 1426 100.0 2267 100.0
Table 3 Estimated odds ratios (OR) and 95% confidence intervals (CIs) on stage, T, N, M in left- and right-sided colon
and rectal adenocarcinoma patients
STAGE T N M
P OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI)
Age at diagnosis <.0001 0.03 <.0001 <.0.01
<50 1.80 (1.41-2.29) 1.15 (0.91-1.45) 1.93 (1.54-2.42) 1.88 (1.40-2.52)
50-59 1.50 (1.24-1.81) 1.27 (1.07-1.50) 1.65 (1.38-1.97) 1.33 (1.05-1.68)
60-69 1.30 (1.11-1.51) 1.22 (1.06-1.40) 1.46 (1.26-1.69) 1.27 (1.04-1.54)
70-79 1.17 (1.01-1.37) 1.17 (1.02-1.33) 1.15 (1.00-1.33) 1.22 (1.01-1.48)
80+ 1.00 1.00 1.00 1.00
Gender 0.39 0.51 0.42 0.19
Female 0.96 (0.87-1.06) 0.96 (0.86-1.08) 1.01 (0.92-1.13) 0.91 (0.80-1.05)
Male 1.00 1.00 1.00 1.00
Side <.0001 <.0001 <.0001 0.25
Right-side 1.45 (1.28-1.64) 3.30 (2.89-3.77) 1.60 (1.42-1.80) 1.14 (0.98-1.34)
Ascending 1.45 (1.26-1.67) 3.07 (2.65-3.56) 1.72 (1.51-1.97) 1.13 (0.95-1.35)
Transverse 1.45 (1.21-1.72) 3.84 (3.15-4.68) 1.38 (1.17-1.63) 1.17 (0.94-1.46)
Left-side 1.19 (1.03-1.36) 2.12 (1.85-2.43) 1.16 (1.01-1.32) 1.08 (0.91-1.28)
Descending 1.56 (1.13-2.15) 2.70 (1.90-3.84) 1.48 (1.11-1.99) 0.95 (0.63-1.42)
Sigmoid 1.15 (0.99-1.32) 2.06 (1.79-2.37) 1.12 (0.98-1.28) 1.10 (0.92-1.31)
Rectum 1.00 1.00 1.00 1.00
ORs additionally adjusted for socioeconomic status, medical region and first-degree family history of CRC.
P refers to the overall P value of the variable in the model and the significant P values and ORs are shown in bold.
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women showed a significant HR of 0.88. Tumor localiza-
tion was a strong predictor of high T, N and stage but a
weaker predictor of M. Rectal tumors had the most
favorable characteristics compared to any colonic subsite.
Right-sided tumors were more advanced than left-sided
tumors for stage, T and N but not for M. The better sur-
vival of patients with left-sided tumors may be explained
by tumor characteristic in the colon. The relatively favor-
able tumor characteristics of rectal cancer would have
predicted a survival better than that for colon cancer
which was not the case. The possible biological differ-
ences between right-sided and left-sided tumors have
been involved in attempts to explain the low efficacy of
colonoscopy to prevent right-sided cancers [21,22].
Although the present data showed somewhat more
advanced tumors in the right side, the differences were
not large, and for M class no differences were found.
Thus tumor characteristics do not appear as likely expla-
nations to the differential colonoscopy success in preven-
tion right-sided and left-sided tumors.
There was a strong and systematic effect of diagnostic
age for the ORs for stage, N and M increased stepwise
for diagnostic age below 80+ years, the reference cate-
gory. The ORs were between 1.80 and 1.93 for those
diagnosed below 50 years compared to the 80+ refer-
ence group. For T the effect was weak and less systema-
tic. The finding of more aggressive tumors among
young patients was opposite to the survival data, which
were better in young patients. Previous results on diag-
nostic age and tumor characteristics have been contra-
dictory but the recent data on colon cancer are in
agreement with the present results: younger patients
present more aggressive and advanced tumors
[11,14-16]. It was interesting that no age effect was
noted for T, i.e., invasiveness of the primary tumor to
near-by tissue structures did not differ between young
and old patients. Yet the tumors of young patients were
able to invade lymph nodes and send distant metastases.
Thus, the overall conclusion is that the poorer survival
of old patients in colon cancer is unlikely to be related
to delayed diagnosis; delayed diagnosis or presentation
may rather be associated with younger patients. It is
possible that more aggressive treatment of the young
patients plays a role in their better survival
[7,8,12,13,29,30]. Yet another puzzling possibility could
be that the metastatic tumor cells of young patients may
be more sensitive to therapy than those of old patients.
However, clinical trials on patients with different ages
give no strong support to such a hypothesis [7,8]. The
difference in survival could be in response to therapy
rather than the therapy itself. Many old patients have
co-morbidities that limit the treatment and that increase
the risk of death [12,13,29].
Conclusions
The most recent data from the Swedish Cancer Regis-
try showed systematically more aggressive tumors in
young compared to old CRC patients. These results
were opposite to the survival data. The poorer survival
of old patients in colon cancer was not related to the
available tumor characteristics. The more aggressive
tumors in the right-sided colon were in partial agree-
ment with the limited colonoscopic success with right-
sided tumors.
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